Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-975,088
Closed -$21.6M 10
2025
Q4
$21.6M Sell
975,088
-40,100
-4% -$958K 7.4% 5
2025
Q3
$27.7M Sell
1,015,188
-161,562
-14% -$4.88M 10.03% 5
2025
Q2
$34.1M Buy
1,176,750
+275,176
+31% +$7.8M 11.56% 3
2025
Q1
$25.9M Buy
901,574
+161,519
+22% +$6.1M 10.01% 4
2024
Q4
$33.1M Buy
740,055
+8,756
+1% +$413K 10.74% 3
2024
Q3
$32.3M Buy
731,299
+45,022
+7% +$1.84M 10.49% 3
2024
Q2
$26.5M Buy
686,277
+289,524
+73% +$11.9M 10.51% 3
2024
Q1
$19.4M Sell
396,753
-116,431
-23% -$5.59M 10.23% 5
2023
Q4
$24.8M Sell
513,184
-37,901
-7% -$1.69M 11.7% 5
2023
Q3
$22.3M Sell
551,085
-39,255
-7% -$1.55M 11.19% 5
2023
Q2
$23.3M Hold
590,340
10.24% 5
2023
Q1
$24.1M Sell
590,340
-41,323
-7% -$1.52M 10.38% 5
2022
Q4
$20.9M Buy
631,663
+283,690
+82% +$8.5M 9.1% 5
2022
Q3
$9.4M Buy
+347,973
New +$10.6M 5.04% 8

Other funds holding DCBO

Long Path Partners's DCBO Position: Q1 2026 in Review

Long Path Partners sold out of Docebo (DCBO) in Q1 2026, closing a stake of 975,088 shares — an estimated $21.6M sold.

Long Path Partners first reported a position in DCBO in Q3 2022 and held it in 14 quarters. The position peaked at $34.1M in Q2 2025. 67 funds tracked by Wall St. Rank hold DCBO as of Q1 2026.

  • Long Path Partners reported no remaining Docebo position as of Q1 2026 after selling out during the quarter.
  • Long Path Partners sold 975,088 Docebo shares in Q1 2026, an estimated $21.6M.
  • Long Path Partners first reported a position in Docebo in Q3 2022 and held it in 14 quarters.
  • Long Path Partners's Docebo position peaked at $34.1M in Q2 2025.
  • 67 funds tracked by Wall St. Rank held Docebo as of Q1 2026.

Based on Long Path Partners's 13F filing for Q1 2026, filed 14 May 2026.